Back to search
FDAFDA · Food and drugs·Recall number D-0205-2024

Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54

Published January 3, 2024 · Recall initiated: December 11, 2023

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
SERTRALINE HYDROCHLORIDE
Manufacturer
Legacy Pharmaceutical Packaging LLC
Distributor
CA and AR
UPC
0368645522548
Lot
Lot #: 222033, exp. date 08/31/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card